Skip to content

Emily Porter Gerson, MD

NPI 1649281122ActiveIndividual· Dermatology· Washington, DC

Dermatology (MD) in Washington, District of Columbia, licensed in MD, with an NPI issued in August 2006. Part D covered 155 prescriptions written in 2024, 92% of them generic. Revance Therapeutics, Inc. was the largest of 2 companies reporting payments in 2025, $50.53 in all, mostly food and beverage.

Overview

NPI1649281122
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 10, 2006
Last updated in NPPESSep 23, 2020
Certified by providerSep 23, 2020

Specialties and licenses

TaxonomyCodeLicenseState
Dermatology Primary207N00000XD61064MD

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Dermatology (DC)
Opt-outPast opt-out Jan 1, 2027 – Jan 1, 2029
Can order and referYes

Part D prescriptions in 2024

Prescriptions (claims)155 · 180 30-day fills
Patients59
Total drug cost$7,836
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$50.53 · 3 payments from 2 companies
  • 2024$100.28 · 5 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$50.53 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Dermatology providers in Washington

All Dermatology providers in District of Columbia →